Geri
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (01541.HK) Fiyatı
01541.HK Hisse Senedi Fiyat Grafiği
IMMUNEONCO-B (01541.HK)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HK$0
0%
$0
Piyasa Kapalı: Jan 29, 16:00:00 HKT
Henüz Veri YokFollow-Up Questions
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'in temel mali tabloları nelerdir?
01541.HK'ün temel finansal oranları nelerdir?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'in geliri segment veya coğrafya bazında nasıl dağılıyor?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. kârlı mı?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'in herhangi bir yükümlülüğü var mı?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
2.3M
EPS (TTM)
-0.93
Dividend yield
--
Piyasa Değeri
--
IMMUNEONCO-B nedir?
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. The company is headquartered in Shanghai, Shanghai and currently employs 195 full-time employees. The company went IPO on 2023-09-05. The firm's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The firm's core product IMM01 is an innovative CD47-targeted molecule. The firm mainly operates its businesses in the domestic and overseas markets.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved